share_log

22nd Century Announces Resignation of John Miller as President of Tobacco

22nd Century Announces Resignation of John Miller as President of Tobacco

22世紀宣佈約翰·米勒辭去菸草總裁的職務
newsfile ·  05/31 04:05

Helped Establish National Scale Distribution and Launch VLN in More Than 5,000 Stores Across the Country

幫助建立全國規模的分銷網絡,並在全國5,000多家商店中推出VLN

Mocksville, North Carolina--(Newsfile Corp. - May 30, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that John Miller has resigned as President of Tobacco, effective August 2, 2024.

北卡羅來納州莫克斯維爾--(新聞檔案公司,2024年5月30日)——專注於減少尼古丁危害的菸草製品公司22世紀集團公司(納斯達克股票代碼:XXII)今天宣佈,約翰·米勒已辭去菸草總裁一職,自2024年8月2日起生效。

Said Larry Firestone, Chairman and CEO: "I want to thank John for the pivotal role he played in the launch of VLN, leveraging his decades of industry experience to help us achieve national-scale distribution and establishing a retail presence in more than 5,000 stores across 26 states. He also played a key role in expanding our CMO business, including our exciting Pinnacle launch as a store brand for one of the top convenience store chains in the country. We are now well positioned to continue building on this incredible footprint as we work to achieve our company objectives."

董事長兼首席執行官拉里·費爾斯通說:“我要感謝約翰在VLN的推出中發揮的關鍵作用,他利用他數十年的行業經驗幫助我們實現全國範圍的分銷,並在26個州的5,000多家門店建立了零售業務。他還在擴大我們的首席營銷官業務方面發揮了關鍵作用,包括我們作爲門店品牌爲該國頂級連鎖便利店之一推出了激動人心的Pinnacle。在努力實現公司目標的過程中,我們現在處於有利地位,可以繼續在這個令人難以置信的足跡上再接再厲。”

About 22nd Century Group, Inc.
22nd Century Group, Inc. (NASDAQ: XXII) is an agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. With dozens of patents allowing it to control nicotine biosynthesis in the tobacco plant, the Company has developed proprietary reduced nicotine content (RNC) tobacco plants and cigarettes, which have become the cornerstone of the FDA's Comprehensive Plan to address the widespread death and disease caused by smoking. The Company received the first and only FDA Modified Risk Tobacco Product (MRTP) authorization for a combustible cigarette in December 2021. The Company is a subsequent participating manufacturer under the Master Settlement Agreement ("MSA") and vertically integrated for the production of its both own products and contract manufacturing operations ("CMO"), which consist primarily of branded filtered cigars and conventional cigarettes.

關於 22 世紀集團有限公司
22nd Century Group, Inc.(納斯達克股票代碼:XXII)是一家農業生物技術公司,專注於通過植物科學減少菸草危害、減少尼古丁菸草以及改善健康和保健。該公司擁有數十項專利,允許其控制菸草廠中的尼古丁生物合成,開發了專有的降低尼古丁含量(RNC)菸草植物和香菸,這些植物和香菸已成爲美國食品藥品管理局解決吸菸引起的大量死亡和疾病的綜合計劃的基石。2021年12月,該公司獲得了美國食品藥品管理局第一份也是唯一一份可燃香菸草產品(MRTP)授權。根據主和解協議(“MSA”),該公司隨後成爲參與的製造商,並進行垂直整合,生產自有產品和合同製造業務(“CMO”),主要包括品牌過濾雪茄和傳統香菸。

Learn more at xxiicentury.com, on Twitter, on LinkedIn, and on YouTube.
Learn more about VLN at tryvln.com.

在 xxiicentury.com、Twitter、LinkedIn 和 YouTube 上了解更多信息。
了解有關 VLN 的更多信息 在 tryvln.com。

Cautionary Note Regarding Forward-Looking Statements
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements, including but not limited to our full year business outlook. Forward-looking statements typically contain terms such as "anticipate," "believe," "consider," "continue," "could," "estimate," "expect," "explore," "foresee," "goal," "guidance," "intend," "likely," "may," "plan," "potential," "predict," "preliminary," "probable," "project," "promising," "seek," "should," "will," "would," and similar expressions. Forward-looking statements include, but are not limited to, statements regarding (i) our strategic alternatives and cost reduction initiatives, (ii) our expectations regarding regulatory enforcement, including our ability to receive an exemption from new regulations, (iii) our financial and operating performance and (iv) our expectations for our business interruption insurance claim. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in "Risk Factors" in the Company's Annual Report on Form 10-K filed on March 28, 2024. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.

關於前瞻性陳述的警示說明
除歷史信息外,本新聞稿中包含的所有陳述、預期和假設均爲前瞻性陳述,包括但不限於我們的全年業務展望。前瞻性陳述通常包含 “預測”、“相信”、“考慮”、“繼續”、“可能”、“估計”、“預期”、“探索”、“預見”、“目標”、“指導”、“打算”、“可能”、“計劃”、“潛在”、“預測”、“初步”、“可能”、“項目”、“有希望”、“尋求” 等術語、” “應該”、“將”、“將” 和類似的表達。前瞻性陳述包括但不限於有關以下方面的陳述:(i)我們的戰略選擇和成本削減計劃,(ii)我們對監管執法的預期,包括我們獲得新法規豁免的能力,(iii)我們的財務和經營業績,以及(iv)我們對業務中斷保險索賠的預期。實際結果可能與前瞻性陳述中的明示或隱含結果存在重大差異。公司於2024年3月28日提交的10-K表年度報告中的 “風險因素” 中列出了可能導致實際業績出現重大差異的重要因素。本新聞稿中提供的所有信息均爲截至本新聞稿發佈之日,除非法律要求,否則公司不承擔任何義務也不打算更新這些前瞻性陳述。

Investor Relations & Media Contact
Matt Kreps
Investor Relations
22nd Century Group
mkreps@xxiicentury.com
214-597-8200

投資者關係與媒體聯繫人
馬特·克雷普斯
投資者關係
22 世紀集團
mkreps@xxiicentury.com
214-597-8200

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論